2008

Journal of Commercial Biotechnology — January 2009

December 29, 2008

The January 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Volume 15, Issue 1 Editorial Biotechnology commercialisation: Getting past the technology-push PDF Yali Friedman Articles Record integrity and licensing your intellectual property PDF John Avellanet NIH assistance for new therapeutic [...]

Read the full article →

Instructor resources for Building Biotechnology

December 18, 2008

Last week I sent an update to my list of biotech educators about the availability of instructor resources for Building Biotechnology. I’m starting to see interest among educators who I didn’t email, so I ‘m posting a follow-up here to spread the word. The instructor resources are free for qualified educators and include figures and [...]

Read the full article →

Biotechnology and the Global Financial Crisis

December 15, 2008

Emergent biotechnology companies are very reliant on capital, often having less than two years capital on hand. Like other businesses with strong needs for cash, one would expect biotechnology companies to be adversely effected by a dearth of capital. The biotechnology financial crisis and request for pass-forward tax breaks have been covered elsewhere; I’ve been [...]

Read the full article →

Ranking International Biotechnology

December 8, 2008

I’m working on an International Biotechnology ranking and comparison for a well-known publication, and am looking for data sets comparing biotechnology activities in different countries as well as interesting anecdotes about successes/failures/challenges encountered in developing biotechnology in different countries as well between countries. If you’ve got comparative data sets or interesting anecdotes, please drop me [...]

Read the full article →

Drug Patent Expirations in December 2008

December 5, 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in December 2008 *Drugs may be covered by multiple patents

Read the full article →

Spread your message with BiotechBlog

December 1, 2008

BiotechBlog is syndicated by BlogBurst, which means that posts are syndicated to outlets such as Reuters, Biospace, San Francisco Gate, and dozens of other media outlets. Post your content on BiotechBlog and have it syndicated across the web. To create a dialogue for important issues in biotechnology, BiotechBlog is adopting an open architecture. All user [...]

Read the full article →

Join the Journal of Commercial Biotechnology Discussion Group

November 21, 2008

Join the Journal of Commercial Biotechnology discussion group on LinkedIn: http://www.linkedin.com/groups?gid=1241807 This group focuses on the biotech industry. The audience and focus are the same as for the Journal of Commercial Biotechnology: Professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep [...]

Read the full article →

Slow Posting — New Project in the Works

November 13, 2008

Those who have been following this blog for long enough probably know what it means when posting slows down — it means that I’ve got a new project in the works. I’m currently working on a new online platform for biotechnology education. It should be ready for beta testing by December first, and formally launch [...]

Read the full article →

Drug Patent Expirations in November 2008

November 3, 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in November 2008 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration ALKERAN Glaxosmithkline melphalan hydrochloride 4,997,651 Nov 18, 2008 BREVIBLOC Baxter Hlthcare Corp esmolol hydrochloride 5,017,609 Nov 21, 2008 BUSPAR Bristol Myers Squibb buspirone hydrochloride 5,015,646 Nov 14, 2008 COVERA-HS Gd Searle [...]

Read the full article →

Journal of Commercial Biotechnology — October 2008

October 20, 2008

The July 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Volume 14, Issue 4 Editorial Continuing education in biotechnology PDF Yali Friedman Articles Can compliance help marketing and business development? PDF John Avellanet Money for nothing? Risks in biopharmaceutical companies [...]

Read the full article →

← Previous Entries